- Home
- CVX vs NVO Comparison
CVX vs NVO Comparison
Compare CVX & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVX
- NVO
- Stock Information
- Founded
- CVX 1879
- NVO 1923
- Country
- CVX United States
- NVO Denmark
- Employees
- CVX N/A
- NVO N/A
- Industry
- CVX Integrated oil Companies
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVX Energy
- NVO Health Care
- Exchange
- CVX Nasdaq
- NVO Nasdaq
- Market Cap
- CVX 291.4B
- NVO 278.0B
- IPO Year
- CVX N/A
- NVO N/A
- Fundamental
- Price
- CVX $138.48
- NVO $65.73
- Analyst Decision
- CVX Buy
- NVO Strong Buy
- Analyst Count
- CVX 14
- NVO 4
- Target Price
- CVX $166.15
- NVO $128.00
- AVG Volume (30 Days)
- CVX 9.3M
- NVO 11.2M
- Earning Date
- CVX 05-02-2025
- NVO 05-07-2025
- Dividend Yield
- CVX 4.94%
- NVO 2.45%
- EPS Growth
- CVX N/A
- NVO 17.93
- EPS
- CVX 8.74
- NVO 3.40
- Revenue
- CVX $195,083,000,000.00
- NVO $43,922,211,349.00
- Revenue This Year
- CVX N/A
- NVO $20.22
- Revenue Next Year
- CVX $1.17
- NVO $16.10
- P/E Ratio
- CVX $15.83
- NVO $19.32
- Revenue Growth
- CVX 1.16
- NVO 24.11
- 52 Week Low
- CVX $132.04
- NVO $57.00
- 52 Week High
- CVX $168.96
- NVO $148.15
- Technical
- Relative Strength Index (RSI)
- CVX 45.17
- NVO 48.22
- Support Level
- CVX $134.62
- NVO $64.40
- Resistance Level
- CVX $137.31
- NVO $69.67
- Average True Range (ATR)
- CVX 2.50
- NVO 1.74
- MACD
- CVX 0.80
- NVO 0.85
- Stochastic Oscillator
- CVX 68.61
- NVO 62.20
About CVX Chevron Corporation
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.